WA company Epichem and the Drugs for Neglected Diseases initiative are collaborating to develop new drugs to treat African sleeping sickness and similar, forgotten diseases. [ + ]

Mesoblast's sister company plans phase II trials for congestive heart failure [ + ]

LCT has doubled both the sample size and dosage for next stage of clinical tria [ + ]

Arana Therapeutics completes research project with CSL [ + ]

Anadis raises over $800,000 in SPP [ + ]

Researchers at the National Institute of Standards and Technology (NIST) have built a system that relies on the ‘noise’ of jiggling electrons as a basis for measuring temperatures with extreme precision. The system may help define the Kelvin.

Stirling wins distribution rights to PetQuench [ + ]

Infection control specialist Nanosonics appoints new CEO [ + ]

HeartWare plans to float 70 million new shares [ + ]

Avexa to collaborate with TargetDrug on HCV program [ + ]

Biofuels - North America and India are into it in a big way, Brazil wants everyone to play, and China is spending a packet to join in. Now a group of Queensland biotechnologists have teamed up with the Swiss to sweeten the game. [ + ]

The ability to diagnose breast cancer by studying human hair may sound a little out there, but Sydney company Fermiscan is about to finalise a validation trial of technology that will do just that. [ + ]

Wei wins premier award for early-career researchers. [ + ]

Victorian company Biosol is pioneering the use of microbial control to reduce corrosion in sewage pipes and cut greenhouse gas emissions at wastewater treatment plants. [ + ]

It's been a big year for Starpharma, the Melbourne-based biotech working on a portfolio of applications for its dendrimer technology. [ + ]